Overcoming Workplace Disability in IBD Patients: An Observational Study
Author:
Publisher
S. Karger AG
Subject
Gastroenterology
Reference13 articles.
1. El-Matary W, Dufault B, Moroz SP, Schellenberg J, Bernstein CN. Education, Employment, Income, and Marital Status Among Adults Diagnosed With Inflammatory Bowel Diseases During Childhood or Adolescence. Clin Gastroenterol Hepatol. 2017 Apr;15(4):518–24.
2. Zand A, van Deen WK, Inserra EK, Hall L, Kane E, Centeno A, et al. Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact. Inflamm Bowel Dis. 2015 Jul;21(7):1623–30.
3. Su HY, Gupta V, Day AS, Gearry RB. Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand. Inflamm Bowel Dis. 2016 Sep;22(9):2238–44.
4. Büsch K, da Silva SA, Holton M, Rabacow FM, Khalili H, Ludvigsson JF. Sick leave and disability pension in inflammatory bowel disease: a systematic review. J Crohn’s Colitis. 2014 Nov;8(11):1362–77.
5. Binion DG, Louis E, Oldenburg B, Mulani P, Bensimon AG, Yang M, et al. Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn’s disease: a meta-analysis. Can J Gastroenterol. 2011 Sep;25(9):492–6.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis;Journal of Crohn's and Colitis;2024-04-22
2. Transitioning patients from intravenous to subcutaneous infliximab and vedolizumab for inflammatory bowel disease: what is the opportunity cost of improving access to healthcare?;Internal Medicine Journal;2024-01-12
3. Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease;Frontiers in Medicine;2023-04-11
4. ‘Why it’s important to talk about our toilet needs in the workplace’ – Using Maslow’s Needs Theory to Shine a Light on Workers Living with IBD in the Workplace;The Qualitative Report;2023-03-27
5. Editorial: earning potential in paediatric‐onset IBD —a complex interplay;Alimentary Pharmacology & Therapeutics;2022-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3